Hemogenyx Net Income From Continuing Ops vs Minority Interest Analysis

HEMO Stock   343.40  20.90  6.48%   
Hemogenyx Pharmaceuticals financial indicator trend analysis is much more than just examining Hemogenyx Pharmaceuticals latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hemogenyx Pharmaceuticals is a good investment. Please check the relationship between Hemogenyx Pharmaceuticals Net Income From Continuing Ops and its Minority Interest accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hemogenyx Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Net Income From Continuing Ops vs Minority Interest

Net Income From Continuing Ops vs Minority Interest Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hemogenyx Pharmaceuticals Net Income From Continuing Ops account and Minority Interest. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Hemogenyx Pharmaceuticals' Net Income From Continuing Ops and Minority Interest is -0.68. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Minority Interest in the same time period over historical financial statements of Hemogenyx Pharmaceuticals PLC, assuming nothing else is changed. The correlation between historical values of Hemogenyx Pharmaceuticals' Net Income From Continuing Ops and Minority Interest is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Hemogenyx Pharmaceuticals PLC are associated (or correlated) with its Minority Interest. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Minority Interest has no effect on the direction of Net Income From Continuing Ops i.e., Hemogenyx Pharmaceuticals' Net Income From Continuing Ops and Minority Interest go up and down completely randomly.

Correlation Coefficient

-0.68
Relationship DirectionNegative 
Relationship StrengthWeak

Net Income From Continuing Ops

Minority Interest

Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Hemogenyx Pharmaceuticals PLC whose combined shares represent less than 50% of the total outstanding shares issued by Hemogenyx Pharmaceuticals have a minority interest in Hemogenyx Pharmaceuticals.
Most indicators from Hemogenyx Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hemogenyx Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hemogenyx Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Selling General Administrative is likely to gain to about 5.2 M in 2024. Issuance Of Capital Stock is likely to gain to about 5.3 M in 2024

Hemogenyx Pharmaceuticals fundamental ratios Correlations

0.91-0.38-0.790.850.850.810.840.480.890.880.590.220.470.870.130.950.730.510.580.960.610.010.20.940.68
0.91-0.7-0.590.960.960.610.630.370.970.710.210.210.260.750.060.760.470.40.260.870.26-0.080.020.80.41
-0.38-0.7-0.14-0.75-0.75-0.150.080.23-0.71-0.030.44-0.160.08-0.070.06-0.130.30.030.47-0.380.470.020.16-0.160.35
-0.79-0.59-0.14-0.5-0.5-0.71-0.98-0.84-0.56-0.97-0.73-0.14-0.53-0.94-0.18-0.85-0.93-0.6-0.83-0.81-0.87-0.04-0.31-0.88-0.91
0.850.96-0.75-0.51.00.650.570.260.990.650.160.260.340.640.040.690.360.320.180.850.220.070.130.680.29
0.850.96-0.75-0.51.00.650.570.260.990.650.160.260.340.640.040.690.360.320.180.850.220.070.130.680.29
0.810.61-0.15-0.710.650.650.770.430.690.810.730.440.660.650.210.770.590.460.550.840.670.270.430.710.53
0.840.630.08-0.980.570.570.770.80.630.990.750.170.50.950.210.880.930.630.860.830.890.00.270.890.9
0.480.370.23-0.840.260.260.430.80.350.780.440.150.270.790.030.510.740.410.660.470.65-0.090.130.650.72
0.890.97-0.71-0.560.990.990.690.630.350.710.210.260.360.70.060.730.410.370.230.880.270.060.140.740.34
0.880.71-0.03-0.970.650.650.810.990.780.710.70.230.50.960.20.880.890.620.80.880.830.00.250.90.85
0.590.210.44-0.730.160.160.730.750.440.210.70.250.60.620.180.730.810.430.830.570.910.150.40.650.8
0.220.21-0.16-0.140.260.260.440.170.150.260.230.250.130.16-0.410.040.1-0.310.040.220.07-0.04-0.020.150.05
0.470.260.08-0.530.340.340.660.50.270.360.50.60.130.370.110.50.420.240.270.550.570.840.950.350.37
0.870.75-0.07-0.940.640.640.650.950.790.70.960.620.160.370.160.870.910.610.780.830.76-0.140.120.930.89
0.130.060.06-0.180.040.040.210.210.030.060.20.18-0.410.110.160.170.130.880.180.20.210.050.090.050.14
0.950.76-0.13-0.850.690.690.770.880.510.730.880.730.040.50.870.170.840.560.740.90.760.020.250.960.8
0.730.470.3-0.930.360.360.590.930.740.410.890.810.10.420.910.130.840.550.930.680.93-0.090.20.851.0
0.510.40.03-0.60.320.320.460.630.410.370.620.43-0.310.240.610.880.560.550.530.550.54-0.040.120.490.55
0.580.260.47-0.830.180.180.550.860.660.230.80.830.040.270.780.180.740.930.530.520.94-0.230.070.730.94
0.960.87-0.38-0.810.850.850.840.830.470.880.880.570.220.550.830.20.90.680.550.520.590.120.290.880.63
0.610.260.47-0.870.220.220.670.890.650.270.830.910.070.570.760.210.760.930.540.940.590.110.40.70.92
0.01-0.080.02-0.040.070.070.270.0-0.090.060.00.15-0.040.84-0.140.050.02-0.09-0.04-0.230.120.110.95-0.15-0.14
0.20.020.16-0.310.130.130.430.270.130.140.250.4-0.020.950.120.090.250.20.120.070.290.40.950.080.16
0.940.8-0.16-0.880.680.680.710.890.650.740.90.650.150.350.930.050.960.850.490.730.880.7-0.150.080.82
0.680.410.35-0.910.290.290.530.90.720.340.850.80.050.370.890.140.81.00.550.940.630.92-0.140.160.82
Click cells to compare fundamentals

Hemogenyx Pharmaceuticals Account Relationship Matchups

Hemogenyx Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.0M2.7M8.5M7.1M6.1M3.5M
Total Stockholder Equity(346.5K)890.8K8.2M3.3M2.8M2.1M
Net Debt758.6K(184.2K)(6.8M)890.1K1.7M1.8M
Retained Earnings(6.0M)(8.0M)(13.1M)(17.1M)(23.8M)(22.6M)
Cash498.7K1.8M6.8M2.5M1.2M1.9M
Cash And Short Term Investments498.7K1.8M6.8M2.5M1.2M1.9M
Common Stock Total Equity3.6M3.6M3.6M4.3M5.0M2.9M
Common Stock Shares Outstanding360.7M414.8M774.0M979.7M1.1B1.2B
Liabilities And Stockholders Equity1.0M2.7M8.5M7.1M6.1M3.5M
Other Current Assets55.8K105.0K298.2K62.0K922.0K968.1K
Total Current Assets554.5K1.9M7.1M2.6M2.2M2.1M
Common Stock3.6M3.6M4.3M9.8M11.8M12.3M
Short Long Term Debt Total1.3M1.6M10.2K3.4M2.9M1.5M
Other Current Liab80.3K47.5K46.9K51.9K77.3K71.2K
Total Current Liabilities181.6K1.8M352.8K748.4K652.1K526.2K
Net Tangible Assets686.4K(608.6K)635.9K7.8M8.9M9.4M
Accounts Payable61.4K113.2K295.8K374.3K301.7K154.9K
Non Current Assets Total495.4K747.3K1.4M4.5M3.9M4.1M
Non Current Liabilities Total1.2M10.0K306.0K3.1M2.7M2.8M
Other Stockholder Equity7.7M10.0M23.0M16.8M14.9M10.1M
Total Liab1.4M1.8M352.8K3.8M3.3M3.5M
Accumulated Other Comprehensive Income452.5K756.9K878.3K(58.8K)1.1M1.1M
Intangible Assets272.8K262.1K255.0K441.5K470.2K356.6K
Property Plant And Equipment Net233.4K268.7K797.1K3.9M3.3M3.5M
Non Currrent Assets Other0.0223.6K142.6K140.8K153.7K155.6K
Net Receivables32.3K56.3K7.5K9.8K5.1K4.9K
Property Plant Equipment173.9K233.4K268.7K797.1K916.7K962.5K
Net Invested Capital797.6K2.5M8.2M3.3M2.8M3.4M
Property Plant And Equipment Gross233.4K268.7K1.1M4.5M4.0M4.2M
Net Working Capital372.9K138.4K6.8M1.8M1.5M2.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hemogenyx Stock Analysis

When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.